Biotechnology Stocks II Dollar-cost Averaging for Mineralys Therapeutics, Inc. (MLYS)

Biotechnology Stocks II: Dollar-cost Averaging for Mineralys Therapeutics, Inc. (MLYS)

Dollar-cost averaging calculator assumes a $1,000 initial investment and a recurring $100 monthly investment.

All values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.

Dollar-cost Average Calculator
Monthly Investments
2023/03/31 - 2025/04/25
StockMLYS
Initial Price$15.6600
Initial Investment$1,000.00
Recurring Monthly Investment$100.00
Initial # Shares Bought63.8570
DCA # Monthly Investments25
DCA Total Monthly Investments$2,500.00
DCA # Monthly Shares Bought215.351
DCA Total Investments$3,500.00
DCA Total # Shares279.208
Final Price$13.3400
DCA Final Value of Total # Shares$3,724.63
DCA Percent Return6.42%
No DCA Total # Shares Bought63.8570
No DCA Final Value$851.85
DCA Final Value - No DCA Final Value ($)$2,872.78
DCA Final Value - No DCA Final Value (%)337.24%
Stock Return Calculator


Not enough prices to do computations.

Previous Stock  TOC  Next Stock

MLYS Performance Table and Chart

MLYS Compare Returns with S&P 500

MLYS Trendline Chart

MLYS Moving Average Chart

MLYS Stock Return Map - See Patterns of Gains and Losses

MLYS Stock Returns/Purchase Dates